Medifast opened lower at $12.24, compared with its previous close of $12.26. In the last trading session, the stock traded between $12.04 and $12.48. It showed a sideways intraday trend.
return calculator
Time Period
An investment of $100 made 5 years ago in Medifast is now worth
$ 6.20
resulting in a loss of
$ 93.80 (93.80%)
invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
No analyst rating data available.
Markets Today
Today's Change
$-0.08 (-0.67%)
Day High
$12.48
Day Low
$12.04
Day Open
$12.24
Prev Close
$12.26
Volume
60,377
1W Return
-0.08%
1M Return
4.84%
3M Return
26.16%
6M Return
11.52%
1Y Return
-0.02%
Fundamentals
Market Cap ($ Mn)
136
PE Ratio
-
PB Ratio
0.69
PEG Ratio
-
ROE
-8.89%
ROCE
-5.12%
EPS (TTM)
$-1.57
Investment Returns
1 Week
-0.08%
1 Month
4.84%
3 Months
26.16%
6 Months
11.52%
9 Months
9.22%
Financials
Quarterly
All values in $ Mn
105.6
Jun 25
89.4
Sep 25
75.1
Dec 25
76.0
Mar 26
76.4
Jun 26
72.0
Sep 26
Updates
15Oct
Medifast Q3FY26 Results: Earnings call set for October 26
Medifast will announce Q3FY26 financial results on October 26, 2026. Conference call scheduled for 8:30 am ET with CEO Nick Johnson and CFO Jim Maloney. Telephonic playback available from 12:30 pm ET on October 26 through November 2, 2026.
15 days ago
27Aug
Medifast launches metabolic health institute to centralize research
Medifast launches the Medifast Metabolic Health Institute to centralize clinical research and education. The move follows the July launch of Trilivy, which replaced OPTAVIA as the consumer brand. The institute leverages over 45 years of research, including 18 randomized controlled trials. Dr. Wayne Scott Andersen serves as Distinguished Fellow, guided by a board formed in 2008. The institute sets standards for the annual Trilivy Coach Certification program.
2mo ago
4Aug
Medifast Q2 loss widens as coach base shrinks by 48.7%
Medifast's Q2 results show a net loss of $3.1 million and a 27.6% revenue decline due to a nearly 50% drop in active coaches. However, per-coach revenue increased 41%, signaling improved productivity amidst structural market challenges.
2mo ago
4Aug
Medifast Q3 Results: Sales guidance widens to $60-$80M range
Medifast forecasts Q3 GAAP EPS of $(0.65)-$(0.15) against a $(0.62) estimate. Sales guidance is set at $60.000M-$80.000M, diverging from the $67.700M analyst consensus, indicating potential revenue volatility.
2mo ago
21Jul
Medifast to announce Q2 FY26 results on August 3
Medifast will announce financial results for the quarter ended June 30, 2026, on August 3, 2026, after market close. A conference call will follow at 4:30 p.m. ET, featuring CEO Nick Johnson and CFO Jim Maloney. The webcast will be archived until November 3, 2026.
3mo ago
17Jul
Medifast launches Trilivy metabolic health system with new science
Medifast launched Trilivy, a comprehensive metabolic health system featuring the Trilivy Reset Fueling line enhanced with MetaVantage Technology. The system targets metabolic dysfunction through Metabolic Synchronization across three phases, aiming to reduce visceral fat and retain lean mass. Newly formulated meal replacements are planned to debut in August.
